Search results for "From ACP Journal Club"


 
Results 81 - 90 of about 129 for "From ACP Journal Club".

Guideline: The USPSTF recommends low- to moderate-dose statins to prevent CVD in selected adults 40 to 75 years of age | ACP Diabetes Monthly

The U.S. Preventive Services Task Force (USPSTF) issued a recommendation on use of statins for primary prevention of cardiovascular disease (CVD).

In uncontrolled type 2 diabetes, CBT improved glycemic control and reduced depression | ACP Diabetes Monthly

Patients with diabetes and depression who received cognitive behavioral therapy (CBT) had improvements in medication adherence, self-monitoring of glucose, depressive symptoms, and HbA1c compared to those who received usual care.

Review: Dipeptidyl peptidase-4 inhibitors do not increase overall adverse events in type 2 diabetes | ACP Diabetes Monthly

A meta-analysis included 67 randomized controlled trials comparing dipeptidyl peptidase-4 (DPP-4) inhibitors to placebo or other oral antidiabetic agents.

In type 2 diabetes treated with high-dose insulin, liraglutide reduced HbA1c | ACP Diabetes Monthly

The hypoglycemia rate was higher in the first month after initiation of liraglutide, but the overall hypoglycemia rate over the 6-month follow-up was similar in liraglutide and placebo patients.

In abstinent adults with type 2 diabetes, a daily glass of wine (vs mineral water) improved cardiometabolic factors | ACP Diabetes Monthly

Drinking red wine, rather than mineral water, with dinner every night for 2 years was associated with improvements in cholesterol markers in patients in Israel. A group assigned to white wine did not show significant differences on these markers

Review: In patients with type 2 diabetes who fast, sitagliptin reduces hypoglycemia more than sulfonylurea | ACP Diabetes Monthly

Patients who took sitagliptin were significantly less likely to have hypoglycemia during Ramadan, according to a systematic review.

October 11, 2013 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Review: Type 2 diabetes screening does not reduce mortality but treating dysglycemia delays onset of diabetes | ACP Diabetes Monthly

A systematic evidence review by the U.S. Preventive Services Task Force found no evidence of mortality benefit from screening for diabetes, based on 2 large randomized controlled trials conducted in the United Kingdom.

November 10, 2017 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

June 14, 2013 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Result Page: Prev   4   5   6   7   8   9   10   11   12   13   Next